share_log

AN2 Therapeutics Q4 EPS $(0.57) Beats $(0.76) Estimate

AN2 Therapeutics Q4 EPS $(0.57) Beats $(0.76) Estimate

AN2 Therapeutics第四季度每股收益美元(0.57美元)超過預期(0.76美元)
Moomoo 24/7 ·  03/28 16:49

AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.76) by 25 percent. This is a 6.56 percent increase over losses of $(0.61) per share from the same period last year.

AN2 Therapeutics(納斯達克股票代碼:ANTX)公佈的季度虧損爲每股0.57美元,比分析師普遍預期的0.76美元(0.76美元)高出25%。這比去年同期每股虧損0.61美元(0.61美元)增長了6.56%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論